The All India Institute of Medical Sciences (AIIMS) based in New Delhi on December 24 invited volunteers for the Phase III clinical trial of the indigenously developed COVID-19 vaccine candidate 'Covaxin' for which it is one of the sites.
https://ift.tt/eA8V8J from https://ift.tt/3nQb9mD
ليست هناك تعليقات:
إرسال تعليق